









市場行情
/
股票
/
nasdaq-bsx
/

Boston Scientific Corp

BSX

92.580USD

+0.820+0.89%

收盤 12/12, 16:00（美東）報價延遲15分鐘

137.23B總市值

49.04本益比TTM



Boston Scientific Corp

92.580

+0.820+0.89%

概覽公司財務分析

概覽

公司

財務

分析

關於 Boston Scientific Corp 公司

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corp簡介



公司代碼BSX

公司名稱Boston Scientific Corp

上市日期May 19, 1992

CEOMahoney (Michael F)

員工數量53000

證券類型Ordinary Share

年結日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編01752-1234

電話15086834000

網址https://www.bostonscientific.com/en-US/Home.html

公司代碼BSX

上市日期May 19, 1992

CEOMahoney (Michael F)

Boston Scientific Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

Mr. Edward J. Ludwig

Lead Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

其他

1.38B

27.25%

地區USD

名稱

營收

佔比

United States

3.22B

63.70%

EMEA (Europe, Middle East and Africa)

878.00M

17.35%

Asia Pacific

790.00M

15.61%

Latin America and Canada

169.00M

3.34%

業務

地區

業務USD

名稱

營收

佔比

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

其他

1.38B

27.25%

股東統計

更新時間: 11月8日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

其他

72.63%

持股股東

佔比

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

其他

72.63%

股東類型

持股股東

佔比

Investment Advisor

50.73%

Investment Advisor/Hedge Fund

29.08%

Hedge Fund

4.91%

Pension Fund

2.94%

Research Firm

2.73%

Bank and Trust

1.88%

Sovereign Wealth Fund

1.58%

Family Office

0.23%

Private Equity

0.18%

其他

5.73%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

2858

1.40B

94.34%

-402.85K

2025Q3

2905

1.40B

94.56%

+9.92M

2025Q2

2818

1.39B

94.08%

+7.87M

2025Q1

2724

1.38B

93.98%

-8.23M

2024Q4

2559

1.38B

93.68%

+12.79M

2024Q3

2401

1.36B

94.13%

-3.01M

2024Q2

2325

1.37B

94.20%

+2.64M

2024Q1

2212

1.37B

95.15%

-32.63M

2023Q4

2153

1.38B

96.34%

-8.17M

2023Q3

2083

1.39B

95.41%

+17.41M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

136.47M

9.21%

+2.53M

+1.89%

Jun 30, 2025

Fidelity Management & Research Company LLC

99.47M

6.71%

-17.98M

-15.31%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

78.19M

5.28%

+380.40K

+0.49%

Jun 30, 2025

State Street Investment Management (US)

65.19M

4.4%

+713.38K

+1.11%

Jun 30, 2025

PRIMECAP Management Company

34.66M

2.34%

-1.83M

-5.03%

Jun 30, 2025

Geode Capital Management, L.L.C.

32.42M

2.19%

+622.60K

+1.96%

Jun 30, 2025

Capital World Investors

28.52M

1.93%

-33.95K

-0.12%

Jun 30, 2025

Managed Account Advisors LLC

22.05M

1.49%

+765.61K

+3.60%

Jun 30, 2025

The Bollard Group, LLC

20.08M

1.36%

-411.38K

-2.01%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

19.46M

1.31%

-275.11K

-1.39%

Jun 30, 2025

持股ETF



更新時間: 12月1日週一

機構名稱

佔比

iShares U.S. Medical Devices ETF

12.15%

Goldman Sachs Future Health Care Equity ETF

8.33%

Invesco Dorsey Wright Healthcare Momentum ETF

3.87%

Tema Heart & Health ETF

3.66%

First Trust Bloomberg R&D Leaders ETF

3.14%

Parnassus Core Select ETF

3.1%

WisdomTree US AI Enhanced Value Fund

3.1%

Health Care Select Sector SPDR Fund

3.06%

Global X Aging Population ETF

2.99%

Proshares Ultra Health Care

2.95%

iShares U.S. Medical Devices ETF

佔比12.15%

Goldman Sachs Future Health Care Equity ETF

佔比8.33%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比3.87%

Tema Heart & Health ETF

佔比3.66%

First Trust Bloomberg R&D Leaders ETF

佔比3.14%

Parnassus Core Select ETF

佔比3.1%

WisdomTree US AI Enhanced Value Fund

佔比3.1%

Health Care Select Sector SPDR Fund

佔比3.06%

Global X Aging Population ETF

佔比2.99%

Proshares Ultra Health Care

佔比2.95%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Boston Scientific Corp的前五大股東是誰？



Boston Scientific Corp的前五大股東如下：
The Vanguard Group, Inc.
持有股份：136.47M
佔總股份比例：9.21%。
Fidelity Management & Research Company LLC
持有股份：99.47M
佔總股份比例：6.71%。
BlackRock Institutional Trust Company, N.A.
持有股份：78.19M
佔總股份比例：5.28%。
State Street Investment Management (US)
持有股份：65.19M
佔總股份比例：4.40%。
PRIMECAP Management Company
持有股份：34.66M
佔總股份比例：2.34%。